These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31677934)

  • 1. International comparison of mitigation strategies for addressing opioid misuse: A systematic review.
    Onwuchekwa Uba R; Ankoma-Darko K; Park SK
    J Am Pharm Assoc (2003); 2020; 60(1):195-204. PubMed ID: 31677934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.
    Mauri AI; Townsend TN; Haffajee RL
    Milbank Q; 2020 Mar; 98(1):57-105. PubMed ID: 31800142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of prescription opioid misuse and abuse.
    Strassels SA
    J Manag Care Pharm; 2009 Sep; 15(7):556-62. PubMed ID: 19739878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid Prescribing.
    Razouki Z; Khokhar BA; Philpot LM; Ebbert JO
    Pain Med; 2019 Oct; 20(10):1934-1941. PubMed ID: 30403814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.
    Ansari B; Tote KM; Rosenberg ES; Martin EG
    Public Health Rep; 2020; 135(1_suppl):100S-127S. PubMed ID: 32735190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions.
    Onishi E; Kobayashi T; Dexter E; Marino M; Maeno T; Deyo RA
    J Am Board Fam Med; 2017; 30(2):248-254. PubMed ID: 28379832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence.
    Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A
    PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.
    Yenikomshian MA; White AG; Carson ME; Garrison LP; Oderda GM; Biskupiak JE; Hlavacek PR; Roland CL
    J Opioid Manag; 2017; 13(5):291-301. PubMed ID: 29199395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State Emergency Department Opioid Guidelines: Current Status.
    Broida RI; Gronowski T; Kalnow AF; Little AG; Lloyd CM
    West J Emerg Med; 2017 Apr; 18(3):340-344. PubMed ID: 28435482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Use After Upper Extremity Surgery.
    Gauger EM; Gauger EJ; Desai MJ; Lee DH
    J Hand Surg Am; 2018 May; 43(5):470-479. PubMed ID: 29602656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Regulations Related to Opioid Prescribing.
    Webster LR; Grabois M
    PM R; 2015 Nov; 7(11 Suppl):S236-S247. PubMed ID: 26568503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in Prescription Opioid Pain Reliever Misuse Across Age Groups: 2015-2017 National Survey on Drug Use and Health.
    Schuler MS; Dick AW; Stein BD
    J Gen Intern Med; 2020 Mar; 35(3):792-799. PubMed ID: 31792871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative outcomes of unbalanced opioid policy supported by clinicians, politicians, and the media.
    Scholten W; Henningfield JE
    J Pain Palliat Care Pharmacother; 2016; 30(1):4-12. PubMed ID: 26890500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. As opioid overdose deaths reach record highs, call for systematic changes grows louder.
    ED Manag; 2016 Feb; 28(2):13-9. PubMed ID: 26939351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic noncancer pain management in primary care: family medicine physicians' risk assessment of opioid misuse.
    Kavukcu E; Akdeniz M; Avci HH; Altuğ M; Öner M
    Postgrad Med; 2015 Jan; 127(1):22-6. PubMed ID: 25539797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.